Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 + cisplatin vs docetaxel + cisplatin in untreated advanced non-small cell lung cancer
jRCT2080221440Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Apr 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in non-small cell lung cancer (NSCLC) comparing S-1 + cisplatin with docetaxel + cisplatin (2 arms).
02
Drugs
tegafurcisplatindocetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCT2080221440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221440.